North America Radiotherapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiotherapy/Radiopharmaceuticals); Product (External Beam Radiotherapy Products, Internal Radiotherapy Products, Radiotherapy Software, and Others); Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others); End User (Hospitals, Radiation Therapy Centers, and Specialty Clinics)
Market Introduction
Radiotherapy is majorly used to control the growth of the tumor and with the minimum exposure to the surrounding normal and healthy tissue. Radiotherapy uses high-energy radiation, generally x-rays, to destroy the cancer cells and treat tumors in the prostate, breast, head & neck, lung and at any other parts in the body where radiation treatment is indicated. Advances in radiotherapy have been made in the last few years, as improvements in imaging modalities, powerful computers and software and delivery systems have enabled technologies.
Thus, the rising prevalence of cancer across the region is expected to create a significant demand for radiotherapy in the coming years, which is further anticipated to drive the radiotherapy market.
Radiotherapy therapies, which are an important part of cancer treatment, have persisted despite the pandemic, but with significant improvements to prioritize care and ensure patient and staff protection. Many organizations have published their best practices in the literature. In July 2020, the article "Oncology-inspired treatment options for COVID-19," published in the Journal of Nuclear Medicine, is one of the first to look at the use of radiation therapy to better treat COVID-19 (SARS-CoV-2) patients. Since the CR3022 human antibody binds to the SARS-CoV-2 virus, researchers at Memorial Sloan Kettering Cancer Center in New York radiolabled it with Iodine-131 (I-131) as a targeted agent. The trials yielded positive results, with an average response rate of 80%. Since then, other low-dose radiotherapy trials have begun in the United States and elsewhere. Dawson introduced a panel discussion on "Low-dose radiation therapy and COVID-19-related pneumonia" at the American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting. The first speaker, Mohammad Khan of Emory University's Winship Cancer Institute, presented the findings of the RESCUE 1-19 trial. RESCUE 1-19 was founded on the idea that LD-RT could aid in the elimination of storming cytokines and unchecked oedema in COVID-19 patients who were hospitalized. radiotherapy might be a treatment option for COVID-19. These factors had a potential impact on the North America radiotherapy market.
Get more information on this report :
Market Overview and Dynamics
The Radiotherapy market in North America is expected to grow from US$ 2,625.7 million in 2021 to US$ 4,007.3 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. Growing implementation of preventive healthcare and disease diagnosis programs is creating lucrative growth opportunities for the radiotherapy market players. For instance, all provinces in Canada have breast cancer screening programs for women with 50–74 years of age. Moreover, in November 2020, the WHO announced initiation of a strategic program to accelerate the elimination of cervical cancer. In order to achieve the objective, the organization announced three key steps – vaccination, screening, and treatment. The governments and healthcare organizations are focusing on implementation of strategic guidelines and policies to accelerate the market growth. For instance, in March 2021, the collaboration by the International Atomic Energy Agency (IAEA) and the WHO issued new guidelines to procure radiotherapy with an aim to improve the access of radiotherapy. These new technical guidelines focus on the selection of radiotherapy equipment, its utilization, and quality maintenance by healthcare facilities. The organizations issued these new guidelines to increase the adoption and awareness of radiotherapy in low and middle-income countries. Such guidelines are also projected to serve a lucrative opportunity for growth of the radiotherapy market during the forecast period.
Key Market Segments
In terms of type, the external-beam radiation therapy segment accounted for the largest share of the North America radiotherapy market in 2020. In terms of product, the external beam radiotherapy products segment accounted for the largest share of the North America radiotherapy market in 2020. In terms of application, the breast cancer segment accounted for the largest share of the North America radiotherapy market in 2020. In terms of end user, the hospitals segment held a larger market share of the radiotherapy market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Radiotherapy market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries, Ltd., Elekta AB, Hitachi, Ltd., Koninklijke Philips N.V., Brainlab AG, PROTOM INTERNATIONAL, and Varian Medical Systems, Inc.
Reasons to buy report
- To understand the North America Radiotherapy market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America Radiotherapy market
- Efficiently plan M&A and partnership deals in North America Radiotherapy market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America Radiotherapy market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
NORTH AMERICA RADIOTHERAPY MARKET SEGMENTATION
By Type
- External-Beam Radiation Therapy
- Internal Radiation Therapy
- Systemic Radiotherapy/Radiopharmaceuticals
By Product
- External Beam Radiotherapy Products
- Internal Radiotherapy Products
- Radiotherapy Software
- Others
By Application
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Cervical Cancer
- Liver Cancer
- Thyroid Cancer
- Lymphoma
- Spine Cancer
- Brain Cancer
- Others
By End User
- Hospitals
- Specialty Clinics
- Radiation Therapy Centres
By Country
- North America
- US
- Canada
- Mexico
Companies Mentioned
- Siemens Healthineers AG
- Accuray Incorporated
- Sumitomo Heavy Industries, Ltd.
- Elekta AB
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Brainlab AG
- PROTOM INTERNATIONAL
- Varian Medical Systems, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Radiotherapy Market – By Type
1.3.2 Radiotherapy Market – By Product
1.3.3 Radiotherapy Market – By Application
1.3.4 Radiotherapy Market – By End User
1.3.5 North America Radiotherapy Market – By Country
2. North America Radiotherapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Radiotherapy Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Radiotherapy Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Radiotherapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cancer across the Region
5.1.2 Increasing Number of Conferences and Symposiums to Boost Awareness About Radiation Therapy
5.2 Market Restraints
5.2.1 Increased Risk of Adverse Effects due to Radiation Therapy
5.3 Market Opportunities
5.3.1 Cancer Screening Programs and Implementation of Standard Guidelines
5.4 Future Trends
5.4.1 Emphasis on Reduced Radiation Exposure Therapies
5.5 Impact Analysis
6. Radiotherapy Market – North America Analysis
6.1 North America Radiotherapy Market Revenue Forecasts and Analysis
7. North America Radiotherapy Market Analysis and Forecasts To 2028 – By Type
7.1 Overview
7.2 Radiotherapy Market Revenue Share, by Type (2020 and 2028)
7.3 External-Beam Radiation Therapy
7.3.1 Overview
7.3.2 External-Beam Radiation Therapy: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Internal Radiation Therapy
7.4.1 Overview
7.4.2 Internal Radiation Therapy: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Systemic Radiotherapy/Radiopharmaceuticals
7.5.1 Overview
7.5.2 Radiotherapy/Radiopharmaceuticals: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8. Radiotherapy Market Analysis – By Product
8.1 Overview
8.2 Radiotherapy Market Revenue Share, by Product (2020 and 2028)
8.3 External Beam Radiotherapy Products
8.3.1 Overview
8.3.2 External Beam Radiotherapy Products: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Internal Radiotherapy Products
8.4.1 Overview
8.4.2 Internal Radiotherapy Products: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Radiotherapy Software
8.5.1 Overview
8.5.2 Radiotherapy Software: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9. Radiotherapy Market Analysis – By Application
9.1 Overview
9.2 Radiotherapy Market Revenue Share, by Application (2020 and 2028)
9.3 Breast Cancer
9.3.1 Overview
9.3.2 Breast Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Lung Cancer
9.4.1 Overview
9.4.2 Lung Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Prostate Cancer
9.5.1 Overview
9.5.2 Prostate Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Colorectal Cancer
9.6.1 Overview
9.6.2 Colorectal Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Lymphoma
9.7.1 Overview
9.7.2 Lymphoma: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Liver Cancer
9.8.1 Overview
9.8.2 Liver Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.9 Thyroid Cancer
9.9.1 Overview
9.9.2 Thyroid Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.10 Brain Cancer
9.10.1 Overview
9.10.2 Brain Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.11 Cervical Cancer
9.11.1 Overview
9.11.2 Cervical Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.12 Spine Cancer
9.12.1 Overview
9.12.2 Spine Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.13 Others
9.13.1 Overview
9.13.2 Others: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Radiotherapy Market Analysis and Forecasts to 2028– By End User
10.1 Overview
10.2 Radiotherapy Market Share, by End User, 2020 and 2028, (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Radiation Therapy Centres
10.4.1 Overview
10.4.2 Radiation Therapy Centres: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Specialty Clinics
10.5.1 Overview
10.5.2 Specialty Clinics: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11. Radiotherapy Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 North America: Radiotherapy Market
11.1.1 Overview
11.1.2 North America: Radiotherapy Market, by Country, 2020 & 2028 (%)
11.1.2.1 US: Radiotherapy Market– Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 US: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 US: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.1.2.1.3 US: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.1.2.1.4 US: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.1.2.1.5 US: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.1.2.2 Canada: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 Canada: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 Canada: Radiotherapy Market, by Type, 2019–2028 (USD Million)
11.1.2.2.3 Canada: Radiotherapy Market, by Product, 2019–2028 (USD Million)
11.1.2.2.4 Canada: Radiotherapy Market, by Application, 2019–2028 (USD Million)
11.1.2.2.5 Canada: Radiotherapy Market, by End User, 2019–2028 (USD Million)
11.1.2.3 Mexico: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 Mexico: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 Mexico Radiotherapy Market, by Type – 2019–2028 (USD Million)
11.1.2.3.3 Mexico Radiotherapy Market, by Product – 2019–2028 (USD Million)
11.1.2.3.4 Mexico Radiotherapy Market, by Application – 2019–2028 (USD Million)
11.1.2.3.5 Mexico Radiotherapy Market, by End User – 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on North America Radiotherapy Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 Siemens Healthineers AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Accuray Incorporated
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sumitomo Heavy Industries, Ltd.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Elekta AB
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Hitachi, Ltd.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Koninklijke Philips N.V.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Brainlab AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 PROTOM INTERNATIONAL
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Varian Medical Systems, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. US Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. US Radiotherapy Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 3. US Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. US Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Radiotherapy Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Radiotherapy Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Radiotherapy Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Radiotherapy Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Radiotherapy Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Radiotherapy Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic Developments Done By Companies
Table 15. Glossary of Terms, Radiotherapy Market
LIST OF FIGURES
Figure 1. Radiotherapy Market Segmentation
Figure 2. North America Radiotherapy Market Overview
Figure 3. External-Beam Radiation Therapy Segment Held Largest Share of Type in Radiotherapy Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Radiotherapy Market - North America PEST Analysis
Figure 6. Radiotherapy Market Impact Analysis of Driver and Restraints
Figure 7. North America Radiotherapy Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Radiotherapy Market Revenue Share, by Type (2020 and 2028)
Figure 9. External-Beam Radiation Therapy: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Internal Radiation Therapy: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Radiotherapy/Radiopharmaceuticals: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Radiotherapy Market Revenue Share, by Product (2020 and 2028)
Figure 13. External Beam Radiotherapy Products: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Internal Radiotherapy Products: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Radiotherapy Software: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Radiotherapy Market Revenue Share, by Application (2020 and 2028)
Figure 18. Breast Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Lung Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Prostate Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Colorectal Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Lymphoma: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Liver Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Thyroid Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Brain Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cervical Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Spine Cancer: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Radiotherapy Market Share, by End User, 2020 and 2028 (%)
Figure 30. Hospitals: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Radiation Therapy Centers: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Specialty Clinics: Radiotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America: Radiotherapy Market, by Key Country – Revenue (2020) (USD Million)
Figure 34. North America: Radiotherapy Market, by Country, 2020 & 2028 (%)
Figure 35. US: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Canada: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Mexico: Radiotherapy Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Impact of COVID-19 Pandemic in North American Country Markets
Figure 39. Growth Strategies Done by the Companies in the Market, (%)
- Siemens Healthineers AG
- Accuray Incorporated
- Sumitomo Heavy Industries, Ltd.
- Elekta AB
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Brainlab AG
- PROTOM INTERNATIONAL
- Varian Medical Systems, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America radiotherapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America radiotherapy market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the radiotherapy market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution